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1108-70 is the Relationship Between Left Ventricular Mass and 
Endotheiium-Dependent Vasodilatory Function 
Independent of Blood Pressure? 
Rioobert Laou-Bula. Rongling Li, Adefisayo Oduwole, Brenda Lankford, Cheryl Pack, 
Jan Morgan, Nkemdiche Sunday, Jeanefte St Vrein, Priscilla Pemu, Elizabeth Ofili, 
Morehouse School of Medicine, Atlanta, Georgia. 
Background: Recent studies reported that increased left ventdcular mass (LVM) is associ- 
ated with impaired endothelium-debendent vasodilatory function (EDF). It is unclear, how- 
ever, whether this relationship is independent of blood pressure (BP) in hypertensives and 
normotensives. Methods: We therefore evaluated the effects of BP on the relationship 
between echocardiographic LVM and EDF in 59 African American (AA) hypertensives 
(49±12 yrs) and 42 AA normotensives (40±11 yrs). LVM was calculated (Devereux for- 
mula) and indexed to body surface area (LVMt) to define the presence of LV hypertrophy 
(LVH) (LVMI >134/110 g/m 2 for men/women). EDF was assessed as flow-mediated ilation 
(FMD) of the brachial artery during reactive hyperemia, using high-resolution ultrasound. 
Results: Compared to normotensives, hypertensives had higher LVMI (105±32 vs. 81±24 
g/m 2, P<0.001) and lower FMD (9:t:6 vs. 16±6%, P<0.0001). In addition, patients with LVH 
had a significantly lower FMD than patients without LVH (7±6 vs. 13±7, P<0.001). FMD 
inversely correlated with LVMI (r =-0.53, P<0.0001), systolic BP (r =-0.45, P<0.0001) and 
diastolic BP (r =-0.43, P<0.0001). Regression coefficients revealed a negative relation 
between LVMI and FMD in univariate model (beta= -0.10, P<0.0001) and after adjusting for 
age, gender, systolic and diastolic BP (beta= -0.05, P<0.05). Conclusion: Impairment of 
FMD is inversely related to LVM, and this relationship appears to persist but likely attenu- 
ated after accounting for the well-known influences of blood pressure. 
1108-91 Exercise Blood Pressure Threshold for Left Ventricular 
Hypertrophy in Normotensive and Hypertensive Middle- 
Aged Men 
Peter Kokkinos. Andreas Pittaras, Athanasios Manolis, Puneet Narayan, Vasilios 
Papademetriou, Veterans Affairs Medical Center, Washington, DisL of Columbia, 
Georgetown University Medical Center, Washington, DisL of Columbia. 
Background: An abnormal rise in systolic blood pressure (SBP) during exercise is associ- 
ated with increased nsk for hypertension (HTN) and left ventdcular hypertrophy (LVH). How- 
ever, the magnitude of change in exercise SBP associated with LVH is not well defined. 
Methods: We assessed left ventricular structure (echocardiography) and exercise blood 
pressure (BP) in middle-aged (52~5 yrs) normctensive (n=133) and hypertensive (n=121) 
men free from heart disease, smoking, and antigypertensive medication, to determine the 
association between left venthcular structure and exercise BP. 
Results: Multiple regression analysis (stepwise) revealed that SBP at 6 minutes of exercise 
was the strongest predictor of left ventricular mass index (LVMI) for normotensive (R2= 0.49) 
and hypertensive men (R2--0.41). Since LVH was defined as LVMI>116 g/m 2, we regressed 
the 6-minute exercise SBP against LVMI for each group. The model revealed that a 
SBP_>167 rnm Hg for normotensive and >160 mm Hg for hypertensive men were the mini- 
mum SBP levels to yield LVMI values >116 g/m 2, LVH was present in 71% of normotensive 
and 90% of the hypertensive men whose SBP met the respective level at 6 minutes of exer- 
cise. Furthermore, these men were 6 times more likely to have LVH (Odds Ratio: 6.0; 
C1:3.6-9.8; p<0.000). Compadsens between those who met or exceeded the respective 
level of SBP at 6 minutes of exercise and those who did not, revealed higher LVMI values 
(129+~2 g/m 2 vs 101_+14 g/m 2 ; p=0.000) for normotensive and (144+21 g/m 2 vs 1~ g/ 
m2; p=0.000) for hypertensive men respectively. 
Conclusions: 1) SBP at 6 minutes of exercise is the strongest predictor of LVH for normo- 
tensive and hypertensive middle-aged men; 2) The exercise BP threshold for LVH appears 
to be a SBP>167 mm Hg for normotensive and _>160 mm Hg for hypertensive men achieved 
at a workload of approximately 7 METe, 
1108-92 Electrocardiographic Markers of Cardiac Hypertrophy 
Show Greater Heritability Than Echocardiographic Left 
Ventricular Mass: A Family Study 
Boneani M. Mavosi, Bernard Keavney, Attila Kardos, Crispin H. Davies, Peter J. Ratcliffe, 
Martin Farrall, Hugh Watkins, Department of Cardiovascular Medicine, John Radcliffe 
Hospital, Oxford, United Kingdom. 
Background: Electrocardiographic and echocardiographic measures of cardiac hypertrophy 
are independent predictors of cardiovascular morbidity and mortality. There is increasing 
evidence to show that echocardiographic left ventricular mass is genetically determined, but 
little is known about the magnitude of genetic determination of electrocardiographic mea- 
sures of cardiac hypertrophy. We set out to assess the hedtability of continuous measures of 
left ventricular hypertrophy determined by electrocardiography and echocerdiography. 
Methods: We studied 955 members of 229 Caucasian extended families, ascertained 
through a hypertensive proband. Electrocardiographic measurements were performed man- 
ually on normal resting 12-lead electrocardiograms, and echocardiographic parameters 
were determined on M-mode images. Sex-specific residuals for left venthcular phenotypes 
were calculated, adjusted for age, systolic blood pressure, weight, height, waist-hip ratio, 
and presence of diabetes. Heritability was estimated from familial correlations with adjust- 
ment for spouse resemblance, and by using vadance components methods with ascertain- 
ment correction for proband status. 
Results: The hedtability estimates (range) were higher for Sokolow-Lyon voltage (39-41%) 
and RaVL voltage (30-31%) than for echocardiographic left ventdcular mass (23-29%). Cor- 
nell voltage, Cornell product, and electrocardiographic left ventricular mass had heritability 
estimates of 19-25%, 28-32%, and 12-18%, respectively. 
Conclusions: The greater heritability of Sokotow Lyon voltage and RaVL voltage suggests 
that electrocardiographic phenotypes may be particularly important for the molecular investi- 
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gation of the genetic susceptibility to cardiac hypertrophy. Finding genes that influence the 
electrocardiographic markers could help unravel the pathophysiology of cardiac hypertrophy 
and lead to improvements in prevention, diagnosis, and treatment of at-dsk populations. 
1108-93 Is Urinary Albumin Excretion an Independent Predictor 
of  Cardiovascular Mortality in Patients With 
Electrocardiographic Left Ventricular Hypertrophy? The 
LIFE Study 
Kristian Wechtell. Michael H. Olsen, Bj~m Dahl~f, Richard B. Devereux, Stevo Julius, 
Sverre E. Kjeldsen, Markku S. Nieminen, Peter M. Okin, Knut Borch-Johnsen, Hans 
Ibsen, Glostrup Univeristy Hospital, Glostrup, Denmark, Weill Medical College of Comell 
University, New York, New York. 
Background: Recently, we found that increased urine albumin/creatinine ratio (UACR) as 
well as electrocardiographic (ECG) left ventricular hypertrophy (LVH) were related to high 
blood pressure (BP) in hypertensive patients independent of age, smoking, prevalence of 
diabetes, suggesting parallel BP-induced cardiac hypertrophy and renal glomerular perme- 
abilty. However, it is not clear whether this predicts an independent effect on mortality. 
Methods: ECG and mornLng spot urine were obtained in 8,165 patients with stage I-III 
hypertension and ECG LVH (Comell voltage-duration or Sokolow-Lyon voltage criteria) 
after 14 days placebo treatment. Renal glomerular permeability was evaluated by UACR 
and was defined as micro- or macroalbuminuda if >3.5 or 35 mg/mol, respectively. 
Results: During 68 [95% CI 67-69] months 592 (6%) deaths occurred. Of these 317 (3.9%) 
were cardiovascular (CV) deaths, which plus non-fatal myocardial infarction and stroke 
compressed the composite primary CV eod-point (n=888, 10.9%). Patients with either 
micro- or macroalbuminuria had on average 1.7 or 4.3-fold higher CV mortality rate, 
respectively, compared to normoalbuminuric patients. Similar micro- or macroalbuminuria 
groups had 1.8 or 2.6-fold higher rates of composite end-point compared to normoalbumin- 
uric patients. CV mortality rate and composite CV end-point rate increased 8- and 9-fold in 
patients with macroalbuminuria nd LVH by both criteria as compared to normoalbuminudc 
patients without LVH by either criterion (all p<0.001 ). When divided into quartiles a striking 
increase in CV end-points was seen in the 3 rd quartile with UACR-values between 1.3-3.9 
g/mmol. Cox regression analysis showed that UACR predicts CV mortality and composite 
CV end points independent of LVH, systolic BP, age, sex, diabetes and smoking. 
Conclusion: UACR is an independent predictor of CV morbidity and mortality, even after 
taking into account baseline ECG LVH and other CV risk factors. The presence of cardiac 
end-orgen damage and albuminuria potentiates the risk of overall mortality. Furthermore, 
the threshold-limit for microalbuminuria in patients with hypertension and LVH should be 
reduced to no more than 1.0 mg/mmol. 
1108-94 Increased Expression of Type-2A and Type-2B Pro~tein 
Phosphatasea During the Development of Left 
Ventricuiar Hypertrophy 
Ramesh C. Guota. Sudhish Mishra, Nivedita Tiwari, Hani N. Sabbah, Henry Ford Health 
System, Detroit, Michigan. 
Background: Type-2B protein phosphatase (PP2B) is implicated in the development of 
LV hypertrophy (LVH). The role of type-2A protein phosphatase (PP2A) in LVH, however, 
is not known. We tested the hypothesis that both PP2A and PP2B are involved in the 
LVH. 
Methods: Expression of the catalytic subunit of PP2A (PP2Ac) and PP2B (PP2Bc) was 
examined by Western blots in SDS-extract of LV rnyocardium obtained from Lewis rats 
(n=t 6) in which LVH was produced using one kidney-one clip (1K1C) and in sham-oper- 
ated rats (n=18). Six rats from each group were sacrificed at 1,4, and 6 weeks thereafter. 
LV weight to body weight (LVW/SW) ratio was used to index of LVH. Western blots were 
quantified in densitometric units and the data expressed as percent change from sham 
values, 
Results: f K1C rats developed LVH as early as week 1 post-operatively and the extent of 
LVH increased progressively thereafter. In LVH rats, PP2Bc but not PP2Ac expression 
increased at week 1. Expression of both PP2Ac and PP2Bc, however, increased signifi- 
cantly at 4 weeks and 8 weeks compared to sham. Both PP2Ac and PP2Bc were lower 
at week 8 compared to week 4 (data in table). 
ConcluFione: The results suggest that increased expression of PP2Sc is associated 
with initiation and progression of LVH. Increased expression of PP2Ac follows at a later 
stage of LVH and may play a role in its progression. These temporal differences in the 
expression of PP2Ac and PP2Bc represent therapeutic opportunities to interfere with the 
LVH process at different sta~es of its evolution. 
LVW/BW (%) PP2Ac (%) PP2Bc(%) 
Week1 117_+.4 100_+7 253+18 
Week 4 135 ± 5 255 + 26* 314 + 11" 
Week 8 t86 + 6 *^ 142 + 15 *^ 183 +_ 8 *^ 
*=P<0.O5 vs Week 1; ^ =P<0.05 vs. Week 4 
1108-95 Older Women With Mi ld Hypertension Have Higher Left  
Ventricular Mass Than Men After Adjustment for Lean 
Body Mass 
Jidono SUNG, Anita C. Bacher, Katherine L Turner, Jarnie R. DeRegis, Paul S. Hees, 
Edward P. Shapiro, Kerry J. Stewart, Johns Hopkins University School of Medicine, 
Baltimore, Maryland. 
Background: When left ventricular mass (LVM) is indexed by measures of body size, such 
as body surface area (BSA) and height, gender difference persist with men having a higher 
LVM index. Recent studies suggest that LVM indexed by lean body mass (LBM) may elimi- 
nate the gender difference seen in general populations. With the novel techniques for 
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LVM indexed by BSA** Height* Height2.7 LBM** 
Male 73 _+ 16 g/m 2 89 ± 21 g/m 33 ± 7 g/m 2"7 2.68 ± 0.52 g/kg 
Female 64± 13 g/m 2 75 ± 13 g/m 33 ± 6 g/m2.7 3.07 ± 0.60 g/kg 
1108-96 Arterial Stiffness and Left Ventricular Geometry and 
Function in Hypertensive Patients With 
Electrocardiographic Left Ventricular Hypertrophy: The 
LIFE Study 
Vittorio Palmieri, Jonathan N. Bella, Mary J. Roman, Eva Gerdts, Vasilios 
Papademetriou, Kristian Wachtell, Markku S. Nieminen, Bj6rn Dahl6f, Richard B. 
Devereux, WeN Medical College of Come//Universi~ New York, New York. 
Background: Arterial stiffness can be assessed by the ratio pulse pressure (PP) over 
echocerdiographic stroke volume (SV). We evaluated relations of arterial stiffness to left 
ventricular (LV) geometry and function in hypertensive patients with electrocardiographic 
(ECG) LV hypertrophy (H). 
Methods: Of participants in the echo-substudy of the Losartan Intervention For Endpoint 
(LIFE) reduction in hypertension study, selected to have ECG-LVH by Cornell voltage-dura- 
tion product or Sokolow-Lyon voltage criteria, no heart failure or severe aortic stenosia, we 
identified 858 subjects (88%, 66+-7 yrs/old) with PP/SV available. The study sample was 
divided in tertiles of PP/SV (cutpoints: 0.86 and 1.11 mm Hg/ml). M-mode and Doppler SV 
were averaged. 
Results: With higher PP/SV, age, proportions of women and diabetics, and systolic blood 
pressure (BP) were higher (all p<0.01); diastolic BP, body height and weight, and SV were 
lower (all p<0.01). Mean BP, totaVHDL cholesterol, urinary albumin/creatinine and propor- 
tion of wall motion abnormalities were similar in tertiles of PP/SV. After adjusting for age, 
gender and body surface area, LV mass and LV intemal diameter were lower while relative 
wall thickness (RWT=LV concentricity) was higher with higher PP/SV (all p<0.01); ejection 
fraction was similar across tertiles (p>0.5) while stress-corrected midwall shortening 
(scMWS) was lower with higher PP/SV (p<0.01). After adjustment for age and gender, LV 
filling parameters and heart rate were similar in tertiles of PP/SV (all p>O.1). In multivariate 
models, independent correlates of PP/SV were older age, lower body weight, female-gen- 
der end diabetes (R=0".48, p<0.00t); higher RWT was related to higher PP/SV independent 
of age, gender, and mean BP (R=0.30, p<0.001); higher LV mass was independently pre- 
dicted by higher SV, male-gender, higher body weight, older age and higher mean BP, but 
not PP (R=0.64, p<0.001); PP/SV was not related to scMWS independent of RWT. 
Conclusions: In elderly hypertensives with ECG-LVH, higher arterial stiffness is related to 
concentric LV geometry, which may offset afterload and preserve LV chamber function, but 
is associated with impaired myocardial function. 
FEATURED ORAL PRESENTATION 
825FO Featured Oral Session.,.Current Topics 
on Hormonal Replacement Therapy 
Monday, March 18, 2002, 2:00 p.m.-3:30 p.m. 
Georgia World Congress Center, Room 160W 
2:15 p.m. 
825FO-2 Add i t ion  of  StaUn Attenuates the Increase in C-React ive 
Protein During Estrogen Replacement Therapy in 
Postmenopeuee l  Women 
Kwano K. Koh, Gyorgy Cseko, William Schenke, Richard O. Cannon, III, NHLBI, 
Bethesda, Maryland. 
Background: Randomized clinical trials have shown that HMG-CoA reductase inhibitor 
(statin) therapy reduces cardiovascular risk, the mechanism of which may include dimin- 
ished arterial inflammation as evidenced by reduction in levels of C-reactive protein (CRP) 
in serum, Because estrogen replacement therapy increases CRP in postmenopausal 
women, which coutd have pro-inflammatory consequences and compromise any benefit to 
cardiovascular risk, we determined whether the addition of statin might modify the estro- 
genic effect on CRP. Methods: in a double blind, 3-period crossover study, we randomly 
assigned 28 healthy postmenopausel women to conjugated equine estrogens (CEE) 0.625 
rag, simvastatin 10 rag, and their combination daily for 6 weeks, with each treatment period 
separated by 6 weeks off drugs. CRP was measured by high sensitivity immunomethc 
assay (sensitivity 0.01mg/dL) before and after 6 weeks of each treatment. Results: CEE 
increased CRP from 0.37 ± 0.06 to 0.65 ± 0.13 mg/dL, simvastatin decreased CRP from 
0.37 ± 0.06 to 0.33 ± 0.05 mg/dL, and the therapies combined increased CRP from 0.38 ± 
0.08 to 0.48 ± 0.08 mg/dL (all P<0.02 vs. respective baseline values), with significant differ- 
ences in changes in CRP levels among these therapies (P<O.05 by ANOVA). Post-hoc 
testing showed that the 29 ± 8 % increase in CRP on the combination of CEE with simvas- 
tatin was significantly less than the 89 ± 32 % increase in CRP on CEE alone (P<0.0t). 
The effect of combination therapy on CRP did not correlate with baseline CRP, or with 
baseline or traatment-inducod changes in levels of LDL cholesterol, HDL cholesterol, inter- 
leukin-6, or brachlal artery flow-mediated ilation as a measure of nitric oxide bioactivity (all 
r<0.32). Conclusion: The combination of statin with estrogen therapy may attenuate the 
potential preinflammatory effect of estrogen administration to postmenopausat women, and 
maximize any benefit of hormone replacement herapy to cardiovascular isk. 
2:30 p.m. 
825FO-3 The Dif ferent ia l  Effects of Hormone Replacement 
Therapy and Selective Estrogen Receptor Modulator on 
Endothelial Function Seem Related to  an Effect on 
Plasma Asymmetric Dimethylarglnine, an Inh ib i tor  o f  
Nitr ic Ox ide  Syntheee  
Giuseppe Mercuro, Massimo Fini, Cristiana Vitale, Otavio Gebara, Sandra Zoncu, 
Mauricio Wajngarten, Antonello Silvestri, Paola Rossini, Josh Antonio E Ramires, 
Giuseose M. Rosano, San Raffae/e Hospital, Rome,/ta/y, University of Cag/ia~ 
Cag/ia~ Italy. 
Background: Hormone replacement therapy (HRT) improves endothelial function in 
postmenopausal women. Although in vitro animal studies suggest that the selective 
estrogen receptor modulator, raloxifene (R), improves endothelial function, its effect in 
women has yielded conflicting results. One mechanism by which HRT may reverse 
endothelial dysfunction and increase NO bioavaitability is by lowering asymmetric dime- 
thylarginine (ADMA), an endogenous inhibitor of nitric oxide (NO) synthase. The aim of 
this study was to evaluate endothelial function and plasma ADMA with HRT or R. 
Methods: Brachlal artery diameter, endothelium-dependent flow-mediated vasodilation 
(FMD) of the brachial artery, and plasma levels of nitrite, nitrate, endothelin-1 and ADMA 
were measured in 20 bostmenopausel women with increased cardiovascular risk, treated 
with either HRT (0.625 conjugated equine estrogens and 2.5 mg medroxyprogesterone 
acetate) or R (60 rag) for 4 weeks in a double-blind, single cross-over study. 
Results: Baseline brechial artery diameters remained unchanged after each treatment 
phase. FMD significantly improved with HRT but not with R. ADMA significantly 
decreased with HRT, while a trend towards increased plasma ADMA levels was noted 
with R. 
Conclusions: HRT improves endothelial function in postmenopausel women at risk of 
cardiovascular disease, which may be due, at least in part, to a reduction in ADMA. In 
contrast, R seems to increase plasma ADMA, which may negatively affect endothelial 
function. 
Baseline HRT R 
FMD (%) 7.4_+.0.5 12.4+_0.6"* 6.1+_2.0 
ADMA 0.76+0.51 0.68_+0.63** 0.80+_0.65 
Nitrite+nitrate (Nox) 41.1_+10.3 47.3+-8.4* 38.8+-6.8 
Endothelin-1 (pg/ml) 3.2+_0.6 2.8_+0.6* 3.2+0.7 
*=p<0.05; **=p<0.01, compared to baseline 
2:45 p.m. 
825FO-4 Hormone Replacement Therapy and Risk of Myocardial 
Infarction in Women With Diabetes 
Aooor S. Gami, R. Scott Wright, Sharonne E. Hayes, Stephen L. Kopecky, Mayo Clinic, 
Rochester, Minnesota. 
Background: The effect of hormone replacement herapy (HRT) on coronary heart disease 
(CHD) in postmenopausal women is controversial Women with diabetes are at markedly 
increased risk of CHD, yet data on HRT in this population is scarce. The purpose of this 
study is to describe the effect of HRT on risk of MI in postmenopausel women with diabetes. 
Methods: We conducted a case-control study in which case subjects (n = 99) were consec- 
utive postmenopausal women with diabetes admitted to our institution from 1998 to 2000 
with a principal diagnosis of ML Control subjects (n = 306), matched in a 3:1 ratio by age 
and admission year, were postmenopausal women with diabetes admitted with principal 
diagnoses other than MI. Medical records were reviewed for demographics, medical history 
including diabetes complications, CHD risk factors, laboratory data, and current medica- 
tions. Differences between case and control groups were assessed by the two-sample T- 
test for continuous variables and the chi-square test for dichotomous variables. The odds 
ratio, adjusted for group differences by logistic regression models, was used to estimate the 
relative risk of incident MI for HRT users. 
Results: Case and control subjects were of similar age (73 years), height (157 cm), and 
weight (77 kg). Case and control groups had similar frequencies of hypertension (73°/°) and 
active cigarette use (8%). Frequencies of use of insulin (53%), oral hypoglycemic agents 
(36%), aspirin (46%), and statins (22%) were similar. Frequencies of diabetic retinopathy 
(19%), neuropethy (21%), and nephropathy (32%) were similar. Average levels of hemoglo- 
bin Alc (8.6%) and creatinine (1.7 mg/dt) were similar. More case subjects had previous MI 
(29% vs. 17°, p = 0.01) and hypercholesterolemia (52% vs. 39%, p = 0.02). Current users 
of estrogen (with or without progesterone) comprised 16% of case and 18% of control sub- 
jects. The relative risk of incident MI for current HRT users was 0.92 (95% CI 0.44 - 1.94). 
assessing body composition and LVM, we examined the gender difference of LVM adjusted 
for LBM in older persons with mild hypertension. 
Method: Fifty-two subjects (22 men and 30 women) with untreated mild hypertension, aged 
55 to 75 years, and otherwise healthy, were examined. Resting BP was obtained at 4 or 5 
visits at least 1 week apart and averaged. Body composition was assessed using dual 
energy X-ray absorptiometry. LVM was determined from MRI and was indexed by BSA, 
height, height 2'7 and LBM. 
Results: There were no gender differences in age, SBP and BMI. Men had higher mean BP, 
uniodexed LVM, and LBM than women. Fat mass and percent body fat were higher in 
women compared to men. Unlike the LVM indexed by other measures, LVM indexed by LBM 
was greater in women than men, as shown in table. In a multiple regression model, gender 
was a predictor of LVM after adjustment for LBM, mean BP, percent body fat and LBM - gen- 
der interaction (adjusted means, female vs. male, 135 ± 8 g vs. 109 ± 12 g, p < 0.05) 
Conclusion: in this population of older persons with mild hypertension, women had a higher 
LVM relative to their lean body size, suggesting that women may be more susceptible to LVH 
than men. 
Table * p < 0.01, ** p < 0.05, male vs. female 
